Guy E. Griesmann

Mayo Clinic — United States

Medicine · Health Sciences

16h-index2.1kcitations47works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Myasthenia Gravis and Thymoma(14), Monoclonal and Polyclonal Antibodies Research(9), Autoimmune Neurological Disorders and Treatments(9), Virus-based gene therapy research(7), Virology and Viral Diseases(6)

Publications47 total

Mutated cancer autoantigen implicated cause of paraneoplastic myasthenia gravis
Muscle & Nerve·2018· 15 cited
Erratum for Tesfay et al., PEGylation of Vesicular Stomatitis Virus Extends Virus Persistence in Blood Circulation of Passively Immunized Mice
Journal of Virology·2015Open Access
PEGylation of Vesicular Stomatitis Virus Extends Virus Persistence in Blood Circulation of Passively Immunized Mice
Journal of Virology·2013· 71 cited
Neutralization capacity of measles virus H protein specific IgG determines the balance between antibody-enhanced infectivity and protection in microglial cells
Virus Research·2012· 12 citedOpen Access
Pinhole micro-SPECT/CT for noninvasive monitoring and quantitation of oncolytic virus dispersion and percent infection in solid tumors
Gene Therapy·2011· 27 cited
Safety Studies on Intrahepatic or Intratumoral Injection of Oncolytic Vesicular Stomatitis Virus Expressing Interferon-β in Rodents and Nonhuman Primates
Human Gene Therapy·2009· 74 citedOpen Access
Concentrations and correlations for eight metals in human liver
International Journal of Environmental Health Research·2009· 14 cited
A584 Preliminary Results of a Phase I Trial of Intravenous MV-NIS for Relapsed/Refractory Multiple Myeloma
Clinical Lymphoma & Myeloma·2009
Pre-Clinical Data and Preliminary Patient Results of Intravenous MV-NIS To Treat Relapsed, Refractory Multiple Myeloma.
Blood·2007
Preclinical Pharmacology and Toxicology of Intravenous MV-NIS, an Oncolytic Measles Virus Administered With or Without Cyclophosphamide
Clinical Pharmacology & Therapeutics·2007· 124 citedOpen Access
Immunoglobulin G Antibody-Mediated Enhancement of Measles Virus Infection Can Bypass the Protective Antiviral Immune Response
Journal of Virology·2006· 62 citedOpen Access
58. Oncolytic Measles Virus Delivery by Infected Cell Carriers–A Strategy To “By-Pass” the Pre-Existing Humoral Immune Response
Molecular Therapy·2006Open Access
Reply
Annals of Neurology·2001· 5 cited
CRMP‐5 neuronal autoantibody: Marker of lung cancer and thymoma‐related autoimmunity
Annals of Neurology·2001· 33 cited
CRMP-5 neuronal autoantibody: Marker of lung cancer and thymoma-related autoimmunity
Annals of Neurology·2001· 565 cited
Lambert‐Eaton Myasthenic Syndrome: Antigenicity of Recombinant Human P/Q‐type Calcium Channel α<sub>1</sub> Subunit Putative Ion Pore Region (Domain IV, S5‐S6)<sup>a</sup>
Annals of the New York Academy of Sciences·1998· 3 cited
A Small Cell Lung Carcinoma Line and Subclone Expressing Nicotinic Acetylcholine Receptors of Muscle and Neuronal Types<sup>a</sup>
Annals of the New York Academy of Sciences·1998· 1 cited
Nicotinic Acetylcholine Receptors of Muscle and Neuronal (α<sub>7</sub>) Types Coexpressed in a Small Cell Lung Carcinoma
Journal of Neurochemistry·1997· 50 cited
Calcium-Channel Antibodies in the Lambert–Eaton Syndrome and Other Paraneoplastic Syndromes
New England Journal of Medicine·1995· 597 citedOpen Access
Nine Residues Influence the Binding of α‐Bungarotoxin in α‐Subunit Region 185–200 of Human Muscle Acetylcholine Receptor
Journal of Neurochemistry·1993· 6 cited
page 1 of 3Next →

Frequent Co-authors

Vanda A. Lennon(25), Mark J. Federspiel(10), Daniel McCormick(10), Stephen J. Russell(8), Wai‐Yee Chan(8), Owen M. Rennert(8), E. H. Lambert(7), Thomas J. Kryzer(5), David Dingli(4), Kah-Whye Peng(4), H J De Aizpurua(4), Edward H. Lambert(3), Zhiya Yu(3), Rae Myers(3), Suzanne Greiner(3), Angela Dispenzieri(3), Glen N. Barber(3), Stephanie K. Carlson(3), Ianko Iankov(3), Fred F. Farris(3)